Article
A retrospective review of pediatric conjunctival tumor cases seen at an ocular oncology service indicates that the vast majority of lesions are benign. Of 262 pediatric tumors, only 3% were malignant, and the most common diagnosis was nevus.
Glaukos announces several positive clinical updates for its iDose platform
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
InflammX Therapeutics enters option agreement with Bausch + Lomb, grants right to acquire the company
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Ocugen doses first patient in phase 1 trial of OCU200 for treatment of diabetic macular edema
Inflammasome Therapeutics expands K8 trial following positive 3-month results